Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DarioHealth (DRIO) Common Equity (2016 - 2025)

DarioHealth filings provide 14 years of Common Equity readings, the most recent being $67.9 million for Q4 2025.

  • On a quarterly basis, Common Equity fell 5.69% to $67.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $67.9 million, a 5.69% decrease, with the full-year FY2025 number at $67.9 million, down 5.69% from a year prior.
  • Common Equity hit $67.9 million in Q4 2025 for DarioHealth, down from $74.9 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $118.1 million in Q2 2021 to a low of $58.1 million in Q4 2023.
  • Median Common Equity over the past 5 years was $76.5 million (2024), compared with a mean of $81.8 million.
  • Biggest five-year swings in Common Equity: soared 866.08% in 2021 and later tumbled 36.92% in 2023.
  • DarioHealth's Common Equity stood at $85.5 million in 2021, then decreased by 6.49% to $80.0 million in 2022, then fell by 27.32% to $58.1 million in 2023, then rose by 23.86% to $72.0 million in 2024, then dropped by 5.69% to $67.9 million in 2025.
  • The last three reported values for Common Equity were $67.9 million (Q4 2025), $74.9 million (Q3 2025), and $64.0 million (Q2 2025) per Business Quant data.